Ethics of smart pills and the dawn of surveillance medicine

Content Notes

Abstract

This presentation will explore the ethics of digital medicine--technology represented by pills that alter our bodily functions alongside sensors that not only collect data about our bodies, but share it with our physicians, family and friends. With FDA approval of the Abilify MyCite system in November 2017, pills now interact with cell phones to track medication adherence, but at what cost? Surveillance medicine stands to redefine the physician patient relationships and raises a host of new ethical issues such as redefining notions of privacy, confidentiality, vulnerability, trust, autonomy, consent, data and device management, dependability, physician autonomy, and equity in access to treatment. This presentation introduces attendees to these technologies and explores the ethical and professional challenges raised as they become more ubiquitous.

General Notes

Tuesday, October 8, 2019; noon to 1 p.m.; Room D1.602. "Ethics of smart pills and the dawn of surveillance medicine". Craig M. Klugman, Ph.D., Professor of Bioethics and Health Humanities and Co-Director of the Bioethics and Society Program, DePaul University.

Table of Contents

Citation

Related URI